Oncology Data Advisor

#OncData delivers up-to-date, clinically relevant content for the multidisciplinary #cancer care team including the latest medical news, research, and more.

[Oncology Data Advisor @OncData]

What do you do when a cancer diagnosis doesn’t fit the clinical picture? @GeorgeSledge51 (@carisls) and Vitor Pastorini (@AONOncology) talk with @Crescent_MD about how intuition and #AI-enabled genomic profiling can help reassess tumor origin.

Watch here! https://t.co/cgkdqbjUtT

[Oncology Data Advisor @OncData]

#AI drugs now reach human trials at a steady pace, but very few get past phase 2. In this blog, @Crescent_MD explores his Cancer Treatment Reviews paper showing that while AI may accelerate discovery, its impact on outcomes is yet unproven.

Read here! https://t.co/poCihSxp5K

[Oncology Data Advisor @OncData]

#Colorectal cancer #screening isn’t one-and-done. In this video, Dr. Ethan Halm of @rutgersifh talks with @HundalJasmin about a 10-year study of #FIT adherence and how proactive outreach supports repeat testing and reduces advanced diagnoses.

Watch here! https://t.co/jpV1Asgmkg

[Oncology Data Advisor @OncData]

Do you spend more time typing notes than talking to patients? In this episode of #OncologyUnfiltered, Melissa Cutrona and Matthew Hadfield explore the #documentation burden and how to return attention where it belongs: direct patient care.

Watch here! https://t.co/8JVZ1SZLSX

[Oncology Data Advisor @OncData]

#GLP1 receptor agonists have transformed obesity and diabetes management, but their evidence in oncology is limited. @HundalJasmin discusses her review exploring #metabolic, clinical, and #survivorship implications of GLP-1s in #BreastCancer.

Watch here! https://t.co/ACykFsnRQN

[Oncology Data Advisor @OncData]

Did you catch @OncData Patient Advocate @WarriorMegsie on today's @GMA segment? 🎗️

Check it out now for incredible insights on self-advocacy, navigating #survivorship, and empowering #BreastCancer thrivers when speaking with their care teams.

🔗https://t.co/xKFJZluGq3

[Oncology Data Advisor @OncData]

#RealWorld data can strengthen oncology decisions but must undergo rigorous validation to be reliable. Jessica Paulus, @OntadaOncology, discusses applying #FDA and #EMA quality frameworks to an EHR platform to ensure that data are fit for use.

Watch here! https://t.co/6nPa7Sv6kx

[Oncology Data Advisor @OncData]

The #INTerpath001 trial marks a historic phase 3 win for individualized #mRNA #cancer #vaccines. In this edition of The Way Ahead, Dr. Waqas Haque (@Crescent_MD) explores how #MachineLearning is shaping patient-specific #neoantigen therapies.

Read here! https://t.co/gXGBnlTmey

[Roupen Odabashian @RoupenMD]

Grateful to be featured by @OncData in their "Exploring AI in Oncology" series, in conversation with @Crescent_MD, talking MeducationAI, why human oversight must stay central to AI in medical education, and practical AI literacy for oncology clinicians.

https://t.co/gmVtP5Mip3

[Oncology Data Advisor @OncData]

In this Exploring AI in Oncology episode, @RoupenMD talks with @WaqasHaqueMD about his path to building @meducationai, an #AI-enabled learning platform for #cancer care professionals, and the need for human oversight in AI-supported education.

Watch here! https://t.co/PUXiAv2vR1

[Oncology Data Advisor @OncData]

In this interview, @RahulBanerjeeMD and Dr. Hans Lee (@SarahCannonDocs) explore how #bispecific antibodies are reshaping #MultipleMyeloma treatment and helping more patients receive advanced care in their local communities.

Watch here! https://t.co/fceSNxwUfr

#MMsm #myeloma

[Oncology Data Advisor @OncData]

#AI is reshaping #oncology, but its most meaningful applications may be less visible than headlines suggest. Watch as @MatthewKurianMD and @HundalJasmin discuss where AI holds the most promise in #BreastCancer today and in the near future.

Watch here! https://t.co/7J1sfIDXD3

[Oncology Data Advisor @OncData]

In this Exploring AI in Oncology episode, @WaqasHaqueMD talks with Kenneth Patrick @SeastedtMD of @RoswellPark about MIRACLE, an #AI platform designed to predict #LungCancer surgery complications and personalize surgical risk assessment.

Watch here! https://t.co/mGN6TDZ9Kf

[Oncology Data Advisor @OncData]

In this episode of #OncologyUnfiltered, Melissa Cutrona and Matthew Hadfield explore how the #oncology community can translate #ClinicalTrial availability into meaningful #access.

🔗 Watch here: https://t.co/6qmAJ9D2Cl

[Oncology Data Advisor @OncData]

In this OncData video, @DrAEvens of @RutgersCancer shares how his team used #simulation modeling to identify operational bottlenecks in the #cancer clinic, redesign operations, and nearly double the number of patients seen each day.

Watch here! https://t.co/B3tz0332M7

[Oncology Data Advisor @OncData]

In this edition of The Way Ahead, @WaqasHaqueMD explores how #AI platforms and natural language models can transform #ClinicalTrial matching from an administrative obstacle into a streamlined, patient-centric gateway to life-saving therapies.

Read here! https://t.co/aCLXv4h79e

[Oncology Data Advisor @OncData]

In this video, Dr. Myron Czuczman @CitiusPharma discusses the evolving treatment landscape for #CutaneousTCellLymphoma (#CTCL), including the approval of denileukin diftitox and the importance of balancing disease control with quality of life.

Watch here! https://t.co/Skx22wOMy6

[Oncology Data Advisor @OncData]

In this Exploring AI in Oncology episode, @WaqasHaqueMD and Saamir Pasha, Senior Biostatistician @Ontada, talk about assessing oncology #RealWorld data quality and how #AI can accelerate complex biostatistical workflows with scientific rigor.

Watch here! https://t.co/AW1FfGzeSr

[Oncology Data Advisor @OncData]

In this episode of #OncologyUnfiltered, Melissa Cutrona and Matthew Hadfield explore the evolving challenges of long-term #immunotherapy management.

🔗Watch here: https://t.co/sYwFloOAh7

#Oncology #CancerCare

[Oncology Data Advisor @OncData]

#ASCO26 saw several advances in #ProstateCancer, with #TALAPRO3 and #PROTEUS standing out as most likely to shape practice. In this update to his @i3Health Virtual Tumor Board, @SFreedlandMD @CedarsSinai highlights emerging therapeutic trends.

Watch here! https://t.co/Opqn2fJg6O